« Back to Record
Citation APA

Wojdacz, T. K., Amarasinghe, H. H., Kadalayil, L., Beattie, A., Forster, J., Blakemore, S. S., Parker, H., Bryant, D., Larrayoz, M., Clifford, R., Robbe, P., Davis, Z. Z., Else, M., Howard, D. D., Stamatopoulos, B., Steele, A., Rosenquist, R., Collins, A., Pettitt, A. A., Hillmen, P., Plass, C., Schuh, A., Catovsky, D., Oscier, D. G., Rose-Zerilli, M. M., Oakes, C. C., & Strefford, J. J. (2019). Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: Results from 3 UK clinical trials. Blood Advances, 3(16), 2474-2481. doi:10.1182/bloodadvances.2019000237


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/296789

Wojdacz, T. K., Amarasinghe, H. H., Kadalayil, L., Beattie, A., Forster, J., Blakemore, S. S., Parker, H., Bryant, D., Larrayoz, M., Clifford, R., Robbe, P., Davis, Z. Z., Else, M., Howard, D. D., Stamatopoulos, B., Steele, A., Rosenquist, R., Collins, A., Pettitt, A. A., Hillmen, P., Plass, C., Schuh, A., Catovsky, D., Oscier, D. G., Rose-Zerilli, M. M., Oakes, C. C., & Strefford, J. J. (2019). Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: Results from 3 UK clinical trials. Blood Advances, 3(16), 2474-2481. doi:10.1182/bloodadvances.2019000237